--:--:--
Stockwatch Reports
…

News Reports / Healthcare / TEM

TEMTempus AI, Inc.

NasdaqGS · Healthcare · Mkt cap $14.3B · Avg vol 6.87M

$78.48

+6.26 (+8.67%)

Quote as of November 2, 2026, 7:12 PM ET

News Impact Report · Published November 2, 2026, 3:56 PM ET

TEM: Tempus AI Posts $904.6M in Q3 FY2026 Revenue as Net Loss Widens to $190.9M

Share

Ticker: TEM | Filing: 10-Q | Filed with the SEC: November 2, 2026 | Current Price: $80.01 (+10.79% today)


What Happened

Tempus AI, Inc. filed its quarterly report (Form 10-Q) with the SEC on November 2, 2026, covering the third fiscal quarter of FY2026. The company reported revenue of $904.6 million for Q3 FY2026, while recording a net loss of $190.9 million and an operating loss of $191.5 million for the same period. Basic and diluted loss per share both came in at -$1.10, underscoring the significant gap between the company's top-line scale and its path to profitability.


Why It Matters

  • Revenue at scale: A quarterly revenue figure north of $900 million signals that Tempus AI has built a substantial and growing commercial operation — a meaningful data point for investors watching whether the company can leverage its AI-driven healthcare data platform into durable, large-scale revenues.
  • Persistent losses: Despite the impressive top line, operating and net losses remain deep at roughly $191 million each. This means the company continues to consume cash at a meaningful rate, and investors will want to scrutinize whether operating leverage is improving over time.
  • Stock reaction: The stock is up 10.79% today, suggesting the market is interpreting the revenue figure as a positive surprise, or that execution at this revenue scale was better than feared. The share price of $80.01 sits just below StockWatch's previously published coverage on this name — context worth keeping in mind as the market digests the full filing.

Analysis

The headline revenue number for Q3 FY2026 is the dominant story here. For a company operating in the AI-enabled healthcare data space, demonstrating the ability to generate revenues approaching $1 billion in a single quarter is a significant commercial milestone, regardless of where the bottom line sits today.

That said, the operating loss of $191.5 million against $904.6 million in revenue translates to an operating margin of approximately -21% — a figure that will remain under scrutiny. Investors and analysts will want to track whether the rate of loss is narrowing as a percentage of revenue on a sequential and year-over-year basis, which would signal the operating leverage story is intact.

The sharp single-day stock move of over 10% suggests the market was positioned cautiously heading into this print, or that the revenue figure beat informal expectations. Either way, the filing will now be combed for segment-level disclosures, cash burn, and guidance language to refine the forward picture.

Investors following our existing coverage on TEM should treat this filing as a material update to the fundamental picture — particularly on the revenue trajectory — while keeping the ongoing loss profile in view as the central unresolved question.

What to watch next:

  • Trend in operating loss margin (is the -21% improving sequentially?)
  • Cash and liquidity disclosures within the full 10-Q filing
  • Any commentary on revenue mix between data licensing, services, and platform segments
  • Whether operating expenses are growing slower than revenue — the key test of scaling efficiency

Disclaimer

This report is a news and informational summary based solely on data extracted from Tempus AI's SEC filing and publicly available market data. It does not constitute investment advice, a solicitation to buy or sell any security, or an equity research recommendation. No rating or price target is issued or implied herein. Investors should conduct their own due diligence and consult a qualified financial adviser before making investment decisions.

Existing Coverage

StockWatch has full coverage on TEM, published 2026-09-15. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-02. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1717115/000119312526442624/tem-20260930.htm

StockWatch initiated coverage · September 15, 2026

TEM: Tempus AI — AI-Driven Precision Medicine Platform Scaling Into a Large Diagnostics TAM

High-beta, high-conviction AI diagnostics story trading well below its 52-week high. At $64.71, TEM sits roughly 38% below its 52-week high of $104.32 and about 59% above its low of $40.77, with a beta of 3.72 that signals extreme sensitivity to rate and risk-sentiment shifts. The $11.6B market cap on a company still posting -$1.44 in EPS reflects the market pricing future data/AI monetization rather than current profitability. Short interest is the standout trading signal. 29.46M sh

+21.3%

Read the full report →

+21.3%

Key Data

Last

$80.01

P&L ($)

+$7.79

P&L (%)

+10.79%

Day Range

$70.30 - $83.42

Volume

14.82M

Market Cap

$14.3B

Previous Close

$72.22

Open

$74.31

52 Week Range

$40.77 - $90.53

Shares Outstanding

177.20M

Public Float

123.35M

Average Volume

6.87M

As of November 2, 2026, 4:02 PM ET

Advertise here
Stockwatch Reports

Free stock market updates, top gainers & losers, and AI-generated stock analyses — updated daily. Real-time price movements, quotes, and coverage for German & U.S. stoc